NO20064499L - Krystallinsk sammensetning inneholdende escitalopram-oksalat - Google Patents

Krystallinsk sammensetning inneholdende escitalopram-oksalat

Info

Publication number
NO20064499L
NO20064499L NO20064499A NO20064499A NO20064499L NO 20064499 L NO20064499 L NO 20064499L NO 20064499 A NO20064499 A NO 20064499A NO 20064499 A NO20064499 A NO 20064499A NO 20064499 L NO20064499 L NO 20064499L
Authority
NO
Norway
Prior art keywords
escitalopram oxalate
particles
composition containing
crystalline
crystalline composition
Prior art date
Application number
NO20064499A
Other languages
English (en)
Norwegian (no)
Inventor
Ken Liljegren
Rikke Eva Humble
Kim Bojstrup Jensen
Troels Volsgaard
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34921251&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20064499(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of NO20064499L publication Critical patent/NO20064499L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20064499A 2004-03-05 2006-10-04 Krystallinsk sammensetning inneholdende escitalopram-oksalat NO20064499L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US55090904P 2004-03-05 2004-03-05
DKPA200400382 2004-03-05
PCT/DK2005/000115 WO2005084643A1 (en) 2004-03-05 2005-02-21 Crystalline composition containing escitalopram oxalate

Publications (1)

Publication Number Publication Date
NO20064499L true NO20064499L (no) 2006-12-04

Family

ID=34921251

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20064499A NO20064499L (no) 2004-03-05 2006-10-04 Krystallinsk sammensetning inneholdende escitalopram-oksalat

Country Status (9)

Country Link
EP (1) EP1732514A1 (ru)
JP (1) JP2007526262A (ru)
AU (1) AU2005218713B2 (ru)
BR (1) BRPI0508266A (ru)
CA (1) CA2558198A1 (ru)
EA (1) EA200601641A1 (ru)
NO (1) NO20064499L (ru)
NZ (1) NZ549100A (ru)
WO (1) WO2005084643A1 (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI347942B (en) * 2005-06-22 2011-09-01 Lundbeck & Co As H Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
EP2086509A1 (en) * 2006-10-20 2009-08-12 Ratiopharm GmbH Escitalopram and solid pharmaceutical composition comprising the same
EP2116231A1 (en) * 2008-05-07 2009-11-11 Hexal Ag Granulate comprising escitalopram oxalate
JP2018016569A (ja) * 2016-07-26 2018-02-01 株式会社トクヤマ （１ｓ）−１−［３−（ジメチルアミノ）プロピル］−１−（４−フルオロフェニル）−１，３−ジヒドロイソベンゾフラン−５−カルボニトリル蓚酸塩の製造方法
JP6554245B1 (ja) * 2019-01-31 2019-07-31 第一工業製薬株式会社 ２，２’−ビス（２−ヒドロキシエトキシ）−１，１’−ビナフタレン粉体

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8814057D0 (en) * 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
KR20040030609A (ko) * 2001-05-01 2004-04-09 하. 룬트벡 아크티에 셀스카브 경상이성체성 순수 에스시탈로프람의 용도
AR034612A1 (es) * 2001-06-25 2004-03-03 Lundbeck & Co As H Proceso para la preparacion del citalopram racemico y/o del s- o r-citalopram mediante la separacion de una mezcla de r- y s-citalopram
ES2280892T3 (es) * 2001-07-31 2007-09-16 H. Lundbeck A/S Composicion cristalina que contiene escitalopram.
TWI306846B (en) * 2002-08-12 2009-03-01 Lundbeck & Co As H Method for the separation of intermediates which may be used for the preparation of escitalopram
RS51092B (sr) * 2002-12-23 2010-10-31 H. Lundbeck A/S. Escitalopram bromhidrat i postupak za njegovo pripremanje
US20050154052A1 (en) * 2003-03-24 2005-07-14 Hetero Drugs Limited Novel crystalline forms of (s)-citalopram oxalate

Also Published As

Publication number Publication date
JP2007526262A (ja) 2007-09-13
AU2005218713B2 (en) 2009-11-19
AU2005218713A1 (en) 2005-09-15
EP1732514A1 (en) 2006-12-20
NZ549100A (en) 2010-02-26
BRPI0508266A (pt) 2007-07-31
CA2558198A1 (en) 2005-09-15
WO2005084643A1 (en) 2005-09-15
EA200601641A1 (ru) 2006-12-29

Similar Documents

Publication Publication Date Title
MX2007012936A (es) Derivados de dihidrobenzofurano y usos de los mismos.
MXPA05010682A (es) Compuestos novedosos.
BRPI0512326A (pt) composições compreendendo anfotericina b, métodos e sistemas
TW200732321A (en) Fast dissociating dopamine 2 receptor antagonists
EA200700566A1 (ru) Фармацевтические композиции, включающие леветирацетам, и способы их получения
WO2010037059A3 (en) Heteroaryl antagonists of prostaglandin d2 receptors
TW200517388A (en) Thiazole derivatives as cannabinoid receptor modulators
SE0302760D0 (sv) New compounds
SE0202241D0 (sv) Novel Compounds
TW200745003A (en) Novel compounds
EA200900828A1 (ru) Соединения и композиции в качестве ингибиторов активности каннабиноидного рецептора 1
WO2009102893A3 (en) Cyclic diaryl ether compounds as antagonists of prostaglandin d2 receptors
JO2578B1 (en) Compounds Theophene benzimidazole
NO20064499L (no) Krystallinsk sammensetning inneholdende escitalopram-oksalat
AR111570A1 (es) Composición farmacéutica que comprende selexipag
PH12020550683A1 (en) Novel bradykinin b2 receptor antagonists
SI1506185T1 (sl) Spojine in njihova uporaba kot inhibitorji 5-HT
EA201000752A1 (ru) Фармацевтическая композиция, содержащая эзетимиб
NO20071314L (no) Peptidiske vasopressinreseptoragonister
SG10201906942PA (en) Piperidine cxcr7 receptor modulators
EA200601194A1 (ru) Новые производные бензофурана, используемые для профилактики или лечения нарушений, связанных с 5-ht-рецептором
UA97826C2 (ru) Быстро диссоциирующие антагонисты рецептора 2 дофамина
MX2022004882A (es) Composicion farmaceutica que comprende selexipag.
ZA202206266B (en) Pd-l1 antagonist compound
JO2642B1 (en) Dopamine 2 receptor antagonists are rapidly hydrolyzed

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: PLOUGMANN & VINGTOFT, POSTBOKS 1003 SENTRUM, 0104

FC2A Withdrawal, rejection or dismissal of laid open patent application